Gazyva (obinutuzumab) in India
Generic name : Obinutuzumab.
Trade name : Gazyva.
Manufacturer information :
Gazyva is manufactured by Genentech, Inc.
Gazyva FDA Approval :
Gazyva first approved November 1st, 2013.
Gazyva Dosage form :
1000 mg/40 mL (25 mg/mL) single-use vial.
Gazyva Indications and Usage :
Chronic Lymphocytic Leukemia
Indicated for previously untreated chronic lymphocytic leukemia in combination with chlorambucil.
Gazyva (Obinutuzumab) availability in India
- You could import this medicine against import permit on Patient Name.
- Please contact ACT Lifesciences Private Limited for further information.